PubMed

Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.

Toledo FG, Sniderman AD, Kelley DE.

Diabetes Care. 2006 Aug;29(8):1845-50.PMID: 16873790 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

Diabetes. 2003 Feb;52(2):453-62.PMID: 12540621 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.

Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD.

Metabolism. 2005 Feb;54(2):264-70.PMID: 15690322 [PubMed - indexed for MEDLINE]Related articles

Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes.

Lingvay I, Raskin P, Szczepaniak LS.

J Diabetes Complications. 2007 May-Jun;21(3):137-42.PMID: 17493545 [PubMed - indexed for MEDLINE]Related articlesFree article

Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients.

Petit JM, Guiu B, Terriat B, Loffroy R, Robin I, Petit V, Bouillet B, Brindisi MC, Duvillard L, Hillon P, Cercueil JP, Verges B.

J Clin Endocrinol Metab. 2009 Oct;94(10):4103-6. Epub 2009 Jul 7.PMID: 19584186 [PubMed - indexed for MEDLINE]Related articles

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, Nozaki Y, Maeyama S, Wada K, Saito S, Terauchi Y, Nakajima A.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S15-21.PMID: 17331160 [PubMed - indexed for MEDLINE]Related articles

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

Gastroenterology. 2008 Jul;135(1):122-30. Epub 2008 Mar 21.PMID: 18474251 [PubMed - indexed for MEDLINE]Related articles

Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, Hsu FC, Lohman KK, Weinberg RB, Wagenknecht LE.

Am J Gastroenterol. 2008 Dec;103(12):3029-35. Epub 2008 Oct 3.PMID: 18853970 [PubMed - indexed for MEDLINE]Related articles

Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.

Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM.

Circulation. 2005 Jun 28;111(25):3465-72.PMID: 15983261 [PubMed - indexed for MEDLINE]Related articlesFree article

Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.

Deeg MA, Buse JB, Goldberg RB, Kendall DM, Zagar AJ, Jacober SJ, Khan MA, Perez AT, Tan MH; GLAI Study Investigators.

Diabetes Care. 2007 Oct;30(10):2458-64. Epub 2007 Jun 26.PMID: 17595355 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.

Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC.

Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E906-16.PMID: 12959938 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of plasma triglycerides in insulin resistance and diabetes.

Ginsberg HN, Zhang YL, Hernandez-Ono A.

Arch Med Res. 2005 May-Jun;36(3):232-40. Review.PMID: 15925013 [PubMed - indexed for MEDLINE]Related articles

Overproduction of large VLDL particles is driven by increased liver fat content in man.

Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H, Borén J.

Diabetologia. 2006 Apr;49(4):755-65. Epub 2006 Feb 4.PMID: 16463046 [PubMed - indexed for MEDLINE]Related articles

Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.

Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCC/EDIC Research Group.

Diabetes Care. 2003 Mar;26(3):810-8.PMID: 12610042 [PubMed - indexed for MEDLINE]Related articlesFree article

Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state.

Cali AM, Zern TL, Taksali SE, de Oliveira AM, Dufour S, Otvos JD, Caprio S.

Diabetes Care. 2007 Dec;30(12):3093-8. Epub 2007 Aug 23.PMID: 17717283 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.

Schonfeld G, Patterson BW, Yablonskiy DA, Tanoli TS, Averna M, Elias N, Yue P, Ackerman J.

J Lipid Res. 2003 Mar;44(3):470-8. Epub 2002 Dec 1.PMID: 12562873 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.

Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.

Metabolism. 2006 Jul;55(7):879-84.PMID: 16784958 [PubMed - indexed for MEDLINE]Related articles

Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size.

Krayenbuehl PA, Wiesli P, Schmid C, Lehmann R, Spinas GA, Berneis K.

Swiss Med Wkly. 2008 May 3;138(19-20):275-80.PMID: 18491240 [PubMed - indexed for MEDLINE]Related articlesFree article

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI.

Diabetes. 2005 Mar;54(3):603-8.PMID: 15734833 [PubMed - indexed for MEDLINE]Related articlesFree article

Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.

Stefan N, Peter A, Cegan A, Staiger H, Machann J, Schick F, Claussen CD, Fritsche A, Häring HU, Schleicher E.

Diabetologia. 2008 Apr;51(4):648-56. Epub 2008 Feb 20.PMID: 18286258 [PubMed - indexed for MEDLINE]Related articles